Home

Andrew Hollman Meyer, Chief Business Officer: Janux Therapeutics JANX Sell · Filed 25/12/03

Trade details

Type
Insider sale
Amount
$88,695
Shares · price
2,700 sh · $32.85 a share
Held after
85,607 sh
Trade date
25/12/01
Filed
25/12/03
Days to filing
2 days

Sold 3.1% of holdings

Share of holding sold
3.1%

Janux Therapeutics trades, last 26 weeks

What else happened in Janux Therapeutics around then

Filed or reported within 30 days of the trade day · 25/11/01~25/12/31

Andrew Hollman Meyer's recent trades

  • Andrew Hollman Meyer

    Planned saleJanux Therapeutics

    $28.2K

    Filed 04/13

  • Andrew Hollman Meyer

    Planned saleJanux Therapeutics

    $2.6M

    Filed 01/26

  • Andrew Hollman Meyer

    Planned saleJanux Therapeutics

    $1.7M

    Filed 01/23

  • Andrew Hollman Meyer

    SellJanux Therapeutics

    $25.8K

    Filed 01/02

  • Andrew Hollman Meyer

    Sell10b5-1 planJanux Therapeutics

    $21.2K

    Filed 25/12/03

Andrew Hollman Meyer, Chief Officer — sold $88.7K of Janux Therapeutics JANX · 3.1% of holdings · 10b5-1 plan | Whalegun